SCIENTIFIC ADVISORY BOARD
Amelia Jernigan, M.D.
Dr. Amelia Jernigan is a Gynecologic Oncologist with the LSU Health Sciences Center Department of Obstetrics and Gynecology. She completed her medical degree at Jefferson Medical College in Philadelphia, PA where she was inducted into the prestigious Alpha Omega Alpha honor society. She then completed her Obstetrics and Gynecology Residency at Johns Hopkins Hospital in Baltimore, MD, where she served as Administrative Chief Resident and won the Ungula Sinistra award in recognition of her surgical skills and exceptional care of women with gynecologic cancer. This was followed by a fellowship in Gynecologic Oncology at the Cleveland Clinic in Cleveland, OH. As a Gynecologic Oncologist she specializes in the use of surgery and chemotherapy to treat gynecologic cancers and gynecologic conditions that require complex surgeries.
Dr. Jernigan is a Fellow in the American College of Obstetrics and Gynecology and is board certified in both Obstetrics and Gynecology and in Gynecology Oncology. She is an active member of the Society of Gynecologic Oncology and has served as a national leader on the communications committee as well as the Annual Meeting Program Committee. She is an active member of the NRG and serves on the Rare Tumors Committee. She serves on the Gynecologic Cancer Steering Committee for the National Cancer Institute and is instrumental in helping to approve and give feedback during the development of national collaborative clinical trials. She has published and presented dozens of scientific abstracts and articles over the past several years and is actively engaged in research, hoping to advance the care and treatment options available to women with gynecologic cancers.
Locally, she serves as an Associate Professor of Gynecologic Oncology at LSU Health in New Orleans and as the Director of Gynecologic Oncology. She serves on the scientific advisory board of CAGLA (Cancer Advocacy Group of Louisiana). She teaches and has mentored several LSU and Tulane students and residents. She has initiated the first ovarian cancer hyperthermic intraperitoneal chemotherapy program (HIPEC) in Louisiana. She has worked closely with her partners and the LSU Cancer Center to build the most robust gynecologic cancer trials menu in the state, and her group are lead enrolling sites for several pivotal clinical cancer trials. She is passionate about bringing the most cutting-edge treatments and exciting science to the patients in our region and ensuring that the treatments of tomorrow are reflective of and serve the women we care for.
Your Support Matters
Donate to CAGLA CARES and make a real, lasting difference in our state’s cancer care.
Watch Video at WWLTV.com
MAKE A DIFFERENCE
Each donation strengthens our efforts towards innovative legislation, advanced cancer research, and enhanced patient care. Back our cause, help us realize a cancer-free Louisiana.